Cantor Fitzgerald Upgrades Ironwood Pharmaceuticals (IRWD) to Hold

July 24, 2013 7:19 AM

Cantor Fitzgerald upgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Sell to Hold with a price target of $10.00 (from $7.00). Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found